CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

3 hedge funds and large institutions have $1.22M invested in Can-Fite BioPharma in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.57K

Top Sellers

1
-$249K
2
-$247K
3
-$80K
4
U
UBS
Switzerland
-$8K
5
Citigroup
Citigroup
New York
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$795K
2
$417K
3
$3.57K
4
–
5
–
6
–
7
–